Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders

NCT07522255 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Bloating
Rifaximin
Functional Bowel Disorder
Irritable Bowel Syndrome
Constipation

Interventions

DRUG: Rifaximin (drug)
DRUG: Placebo

Sponsor

Mahidol University